232
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Phenotypic characterization of circulating endothelial cells induced by inflammation and oxidative stress in ankylosing spondylitis

, , , , , , , , , & show all
Pages 768-780 | Received 05 Oct 2020, Accepted 24 Dec 2020, Published online: 01 Feb 2021

References

  • Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007;369(9570):1379–1390.
  • Dougados M, Van der Linden S, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991;34(10):1218–1227.
  • Dean LE, Jones GT, MacDonald AG, et al. Global prevalence of ankylosing spondylitis. Rheumatology. 2014;53(4):650–657.
  • Malaviya AN, Shankar S, Arya V, et al. Indian Rheumatology Association consensus statement on the diagnosis and treatment of axial spondyloarthropathies. Ind J Rheumatol. 2010;5(1):16–34.
  • Pedersen OB, Svendsen AJ, Ejstrup L, et al. Ankylosing spondylitis in Danish and Norwegian twins: occurrence and the relative importance of genetic vs. environmental effectors in disease causation. Scand J Rheumatol. 2008;37(2):120–126.
  • Costantino F, Breban M, Garchon HJ. Genetics and functional genomics of spondyloarthritis. Front Immunol. 2018;9:2933.
  • Peters MJ, Van der Horst-Bruinsma IE, Dijkmans BA, et al. Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum. 2004;34(3):585–592.
  • Lautermann D, Braun J. Ankylosing spondylitis-cardiac manifestations. Clin Exp Rheumatol. 2002;20(6 Suppl 28):S11–S5.
  • Sari I, Okan T, Akar S, et al. Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology (Oxford)). 2006;45(3):283–286.
  • Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, et al. The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease. Medicine. 2009;88(6):358–365.
  • Dougados M, Baeten D. Spondyloarthritis. The Lancet. 2011;377(9783):2127–2137.
  • Zhao W, Feng H, Guo S, et al. Danshenol A inhibits TNF-α-induced expression of intercellular adhesion molecule-1 (ICAM-1) mediated by NOX4 in endothelial cells. Sci Rep. 2017;7(1):1–3.
  • Silva BR, Pernomian L, Bendhack LM. Contribution of oxidative stress to endothelial dysfunction in hypertension. Front Physiol. 2012;3:441.
  • Ozgocmen S, Sogut S, Ardicoglu O, et al. Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis. Rheumatol Int. 2004;24(2):80–83.
  • Stanek A, Cieślar G, Romuk E, et al. Decrease in antioxidant status of plasma and erythrocytes from patients with ankylosing spondylitis. Clin Biochem. 2010;43(6):566–570.
  • Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature.1980;288(5789):373–376.
  • Vanhoutte PM. Endothelial dysfunction and atherosclerosis. European Heart Journal. 1997;18(suppl E):19–29.
  • Milstien S, Katusic Z. Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochem Biophys Res Commun. 1999;263(3):681–684.
  • Aird WC. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res. 2007;100(2):174–190.
  • Lin Y, Weisdorf DJ, Solovey A, et al. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest. 2000;105(1):71–77.
  • Farinacci M, Krahn T, Dinh W, et al. Circulating endothelial cells as biomarker for cardiovascular diseases. Res Pract Thromb Haemost. 2019;3(1):49–58.
  • Yu HK, Lee HJ, Choi HN, et al. Characterization of CD45-/CD31+/CD105+ circulating cells in the peripheral blood of patients with gynecologic malignancies. Clin Cancer Res. 2013;19(19):5340–5350.
  • Linden SV, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27(4):361–368.
  • SieperJ, RudwaleitM, BaraliakosX, et al. The Assessment of Spondyloarthritis International Society (ASAS) handbook: a guide to assess spondyloarthritis. Annals of the Rheumatic Diseases. 2009;68(Suppl 2):ii1–44.
  • Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am CollCardiol.2002;39(2):257–265.
  • Adhikari MC, Guin A, Chakraborty S, et al. Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study. Sem Arthritis Rheumat. 2012;41(5):669–675.
  • Persson J, Stavenow L, Wikstrand J, et al. Noninvasive quantification of atherosclerotic lesions. Reproducibility of ultrasonographic measurement of arterial wall thickness and plaque size. Arterioscler Thromb. 1992;12(2):261–266.
  • Ghasemi A, Hedayati M, Biabani H. Protein precipitation methods evaluated for determination of serum nitric oxide end products by the Griess assay. Jmsr. 2007;2(15):29–32.
  • Jenjaroen K, Chumseng S, Sumonwiriya M, et al. T-cell responses are associated with survival in acute melioidosis patients. PLOS Negl Trop Dis. 2015;9(10):e0004152.
  • Kundu S, Ghosh P, Datta S, et al. Oxidative stress as a potential biomarker for determining disease activity in patients with rheumatoid arthritis. Free Radic Res. 2012;46(12):1482–1489.
  • Mitra S, De Sarkar S, Pradhan A, et al. Levels of oxidative damage and proinflammatory cytokines are enhanced in patients with active vitiligo. Free Radic Res. 2017;51(11–12):986–994.
  • Papagoras C, Voulgari PV, Drosos AA. Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis. Clin Exp Rheumatol. 2013;31(4):612–620.
  • Celermajer DS. Endothelial dysfunction: does it matter? Is it reversible?J Am Coll Cardiol. 1997;30(2):325–333.
  • Popescu C, Trandafir M, Bădică AM, et al. Ankylosing spondylitis functional and activity indices in clinical practice. Journal of Medicine and Life. 2014;7(1):78.
  • Marla SS, Lee J, Groves JT. Peroxynitrite rapidly permeates phospholipid membranes. Proc Natl Acad Sci USA. 1997;94(26):14243–14248.
  • Steyers CM, Miller FJ. Endothelial dysfunction in chronic inflammatory diseases. Int J Mol Sci. 2014;15(7):11324–11349.
  • Wang C, Liao Q, Hu Y, et al. T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis. Exp Ther Med. 2015;9(1):250–256.
  • Liao HT, Lin YF, Tsai CY, et al. Regulatory T cells in ankylosing spondylitis and the response after adalimumab treatment. Joint Bone Spine. 2015;82(6):423–427.
  • Ågren MS, Schnabel R, Christensen LH, et al. Tumor necrosis factor-α-accelerated degradation of Type I collagen in human skin is associated with elevated matrix metalloproteinase (MMP)-1 and MMP-3 ex vivo. Eur J Cell Biol. 2015;94(1):12–21.
  • Maksymowych WP, Rahman P, Reeve JP, et al. Association of the IL1 gene cluster with susceptibility to ankylosing spondylitis: an analysis of three Canadian populations. Arthritis Rheum. 2006;54(3):974–985.
  • Guillot M, Charles AL, Chamaraux-Tran TN, et al. Oxidative stress precedes skeletal muscle mitochondrial dysfunction during experimental aortic cross-clamping but is not associated with early lung, heart, brain, liver, or kidney mitochondrial impairment. J Vasc Surg. 2014;60(4):1043–1051.
  • Higashi Y, Maruhashi T, Noma K, et al. Oxidative stress and endothelial dysfunction: clinical evidence and therapeutic implications. Trends Cardiovasc Med. 2014;24(4):165–169.
  • Lin X, David CA, Donnelly JB, et al. A chemical genomics screen highlights the essential role of mitochondria in HIF-1 regulation. Proc Natl Acad Sci USA. 2008;105(1):174–179.
  • Bertolini F, Shaked Y, Mancuso P, et al. The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat Rev Cancer. 2006;6(11):835–845.
  • Strijbos MH, Verhoef C, Gratama JW, et al. On the origin of (CD105+) circulating endothelial cells. Thromb Haemost. 2009;102(2):347–351.
  • Berx G, Van Roy F. Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol. 2009;1(6):a003129.
  • Arai T, Kelly SA, Brengman ML, et al. Ambient but not incremental oxidant generation effects intercellular adhesion molecule 1 induction by tumuor necrosis factor-α in endothelium. Biochem J. 1998;331(3):853–861.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.